Fulgent Genetics, Inc. (FLGT) vs MiMedx Group, Inc. (MDXG)

A side-by-side comparison of Fulgent Genetics, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FLGT vs MDXG

growth of $100 · dividends reinvested · last 10y
FLGT +130.1% (+8.7%/yr)MDXG -48.5% (-6.4%/yr)FLGT compounded faster over this window
05001k2kStart $10020182020202220242026$230$52
FLGT MDXG

FLGT vs MDXG: by the numbers

  • •MDXG is the larger company ($670M vs $594M market cap).
  • •MDXG is profitable (1.76% net margin) while FLGT runs a net loss (-26.05%).
  • •MDXG grew revenue faster over the past five years (6.36% vs -18.66% CAGR).

Metrics side by side

Valuation

MetricFLGTMDXG
P/E ratioN/A114.88
P/S ratio1.831.89
P/B ratio0.593.10
EV / EBITDAN/A26.24
FCF yieldN/A6.06%

Profitability

MetricFLGTMDXG
Gross margin35.58%78.85%
Operating margin-28.23%15.26%
Net margin-26.05%1.76%
ROE-8.42%2.89%
ROIC-11.80%1.97%

Growth (annualized)

MetricFLGTMDXG
Revenue CAGR (5Y)-18.66%6.36%
Total return CAGR (5Y)-22.38%-4.94%

Frequently asked

Which has grown faster, FLGT or MDXG?
Over the past five years, MDXG grew revenue faster — FLGT at a -18.66% CAGR versus MDXG at 6.36%.
Is FLGT or MDXG more profitable?
MDXG runs the higher net margin — FLGT at -26.05% versus MDXG at 1.76%.
How have FLGT and MDXG total returns compared?
Over the past 10 years, FLGT delivered 8.90% and MDXG delivered -6.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.